Condition
FAP clinical trials and research
As of November 12, 2026, Find a Trial lists 9 FAP clinical trials that are recruiting, at sites in 4 countries (most in China (4), Belgium (2), Italy (2)). By phase: Phase 2 (1), Phase 2/3 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 4Countries
Newest FAP clinical trials
All recruiting trials (9)
-
Classifying duodenal polyps in familial adenomatous polyposis
This project will test two risk models to see if they better predict dangerous duodenal polyps and cancer risk in people with genetically confirmed FAP.
-
Using a new imaging technique to detect cancer-associated fibroblasts in various cancers
This study is testing a new imaging method to see if it can better detect certain cancer-related cells in people with newly diagnosed esophageal or pancreatic cancer compared to standard imaging techniques.
-
Using video capsules to examine patients with Lynch Syndrome
This study is testing whether video capsules can be a good alternative to regular colonoscopies for people with Lynch Syndrome to help improve cancer screening.
-
Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients
This study is testing a special type of imaging called PSMA PET/CT to see if it can help find cancer in adults who have or might have prostate cancer.
-
Testing [177Lu]Lu-OncoFAP-23 alone or with L19-IL2 for metastatic FAP-positive solid tumors
This study will test whether the radioligand [177Lu]Lu-OncoFAP-23, given alone or together with the antibody-cytokine L19-IL2, is safe and shows early benefit in adults with advanced or metastatic FAP-positive solid tumors.
-
Using 18F-FAPI-04 PET imaging for cancer diagnosis and monitoring
This study is testing a new type of imaging called 18F-FAPI-04 PET to see if it can help doctors better diagnose and monitor different kinds of cancer.
-
Imaging with 68Ga-PSFA in patients with specific cancer markers
This study is testing a new imaging agent to see if it can help find cancer spots in patients with certain cancer markers.
-
Evaluating FAP as a biomarker for fibrotic lung diseases
This study is testing if a protein called FAP can help doctors understand and track fibrotic lung diseases like idiopathic pulmonary fibrosis by looking at its levels in different samples and using special scans before and after treatments.
-
Imaging with a new PET agent for SSTR2 positive diseases
This study is testing a new imaging agent to see if it can provide better results for patients with SSTR2 positive diseases compared to the current standard imaging method.
Related topics
Quick answers
How many FAP clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (4 trials), Belgium (2 trials), Italy (2 trials), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 2/3: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.